• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Mankind Pharma Limited — Board Meeting, 03-02-2026: Outcome of Board Meeting

    03-02-2026 | 04:24 pm

    Mankind Pharma's Board approved Q3 & 9M FY26 consolidated financial results. Revenue hit ₹3,567.20 Cr for the quarter, with PAT at ₹408.75 Cr. The acquisition of the Women's Health Portfolio from BSV (WOS) for ₹797 Cr was completed effective Nov 1, 2025.

    No comments yet. Be the first to comment!

    All announcements from Mankind Pharma Limited